NL-OMON49930
Withdrawn
Not Applicable
Immune cell activation following ischemic cerebrovascular events: a multimodal exploratory study - Immune Activation after Stroke
niversitair Medisch Centrum0 sites10 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversitair Medisch Centrum
- Enrollment
- 10
- Status
- Withdrawn
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •\- Age \>18 years
- •\- Stroke or TIA with signs or ischemia on imaging compatible with the
- •neurological deficit.
- •\- Scheduled for carotid endarterectomy based on current clinical standards
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •\- Severe disability (stay in nursing home).
- •\- Auto\-immune or auto\-inflammatory disease
- •\- Current use of immunomodulating drugs
- •\- Recent infection with fever \>38\.5 C \< 1 month ago.
- •\- Pregnancy
- •\- Renal insufficiency (MDRD \<30 ml/min)
- •\- Allergy for FDG or components thereof
- •\- Breastfeeding
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Potential Risk Factors for StrokeCarotid AtherosclerosisCerebrovascular AccidentDiabetes MellitusHypercholesterolemiaHypertensionNCT00001368National Institute of Neurological Disorders and Stroke (NINDS)500
Completed
Not Applicable
Stroke-induced Immunodepression in NeurorehabilitationStrokeLymphopeniaImmunosuppressionNCT05889169IRCCS National Neurological Institute "C. Mondino" Foundation90
Recruiting
Not Applicable
Research for the effect of brain-immune interactioBrain-immune interaction researchJPRN-jRCT10902202901,000
Completed
Not Applicable
Autoimmune Phenomena After Acute StrokeStrokeNCT01082783Charite University, Berlin, Germany28
Completed
Not Applicable
Brain Death: Inflammatory Response, Apoptosis, and Endotoxin ToleranceBrain DeathNCT00615225Delafontaine Hospital